Researchers have observed hydrogen and deuterium molecules in tiny spaces called picocavities using advanced spectroscopy. This study reveals unique differences between the molecules due to quantum ...

Chemists have developed an efficient skeletal editing method for frequently used heteroaromatic structures. The technique could serve as a means to chemically modify biologically active compounds.

Discover seven lung cancer companies advancing promising candidates through the clinic, from viral immunotherapies to ...

Dr. Daniel P. Petrylak sits down with CURE during Bladder Cancer Awareness Month to discuss key topics for patients with the ...

High-resolution cryoEM structures of the intron in different liganded states not only reveal molecular interactions that rationalize experimental structure–activity relationship but also shed light on ...

Merck & Co. ‘s planned debut this fall of an injectable form of its breakthrough cancer treatment Keytruda will simplify care, expand access, and save more lives, the company says. But by shifting ...

“And now that we have this structure, perhaps we can find ways ... showing that it is a molecular complex made of two proteins, TAS1R2 and TAS1R3. One latches on to the sweet molecule, and ...

Nutrients, defined as the chemical substances essential for sustaining the basic functions of the body, are typically categorized into six major classes: carbohydrates, lipids, proteins ...

Keytruda is set to lose exclusivity in 2028, meaning Summit may face competition from cheaper biosimilars. Meanwhile, other branded drugmakers are also seeking to improve on the blockbuster checkpoint ...

Phase 1b/2a trial designed to evaluate the safety and feasibility of IFx-Hu2.0 in combination with Keytruda® when administered via Interventional Radiology (IR) in patients with deep- seated ...

This part of the Phase II study evaluates eftilagimod alfa (efti) in combination with MSD’s (Merck & Co., Inc., Rahway, NJ, USA) anti-PD-1 therapy KEYTRUDA® (pembrolizumab) as first line ...